As shown by the results of this study the histological classification of intraoral salivary gland tumours remains difficult, even when applying the newWHO classification.7 In 29% of cases the original histological diagnosis was changed. In most of these cases the change of diagnosis occurred either within the benign or within the malignant tumour group. In adenocarcinomas more detailed histological typing may lead to a better prediction of the prognosis. This seems especially true with regard to the polymorphous low grade adenocarcinoma. However, the clinical relevance of the new subtyping of adenomas seems somewhat questionable, although it has been claimed that the myoepithelioma is a potentially more aggressive neoplasm.5
In seven cases there was a change in diagnosis from benign to malignant, or vice versa. Benign tumours of the minor salivary glands tend to be non-encapsulated which can make the differentiation between adenomas and carcinomas difficult-for example, the differential diagnosis between pleomorphic adenoma and polymorphous low grade adenocarcinoma.
The follow up data of this study did not corroborate the accuracy of the reclassified diagnoses. 
